Cost-Effectiveness of Chimeric Antigen Receptor T Cell Therapy in Patients with Relapsed or Refractory Large B Cell Lymphoma: No Impact of Site of Care

被引：0
|
作者：
Alice Kate Cummings Joyner
Julia Thornton Snider
Sally West Wade
Si-Tien Wang
Marric G. Buessing
Scott Johnson
Usama Gergis
机构：
[1] Medicus Economics,
[2] LLC,undefined
[3] Kite,undefined
[4] A Gilead Company,undefined
[5] Wade Outcomes Research and Consulting,undefined
[6] Thomas Jefferson University Hospital,undefined
来源：
Advances in Therapy | 2022年 / 39卷
关键词：
Axicabtagene ciloleucel; CAR T cell therapy; Chimeric antigen receptor T cell therapies; Cost-effectiveness; Lisocabtagene maraleucel; Relapsed/refractory large B cell lymphoma; Tisagenlecleucel;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3560 / 3577
页数：17
相关论文
共 50 条
  • [1] Cost-Effectiveness of Chimeric Antigen Receptor T Cell Therapy in Patients with Relapsed or Refractory Large B Cell Lymphoma: No Impact of Site of Care
    Joyner, Alice Kate Cummings
    Snider, Julia Thornton
    Wade, Sally West
    Wang, Si-Tien
    Buessing, Marric G.
    Johnson, Scott
    Gergis, Usama
    [J]. ADVANCES IN THERAPY, 2022, 39 (08) : 3560 - 3577
  • [2] Cost-effectiveness of chimeric antigen receptor T-cell therapy in multiply relapsed or refractory adult large B-cell lymphoma.
    Lin, John
    Muffly, Lori S.
    Spinner, Michael Alexander
    Barnes, James I.
    Owens, Douglas K.
    Goldhaber-Fiebert, Jeremy D.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [3] Cost-effectiveness of chimeric antigen receptor T-cell therapy in adults with relapsed or refractory follicular lymphoma
    Potnis, Kunal C.
    Di, Mengyang
    Isu, Iris
    Gowda, Lohith
    Seropian, Stuart E.
    Foss, Francine M.
    Forman, Howard P.
    Huntington, Scott F.
    [J]. BLOOD ADVANCES, 2023, 7 (05) : 801 - 810
  • [4] Cost Effectiveness of Chimeric Antigen Receptor T-Cell Therapy in Multiply Relapsed or Refractory Adult Large B-Cell Lymphoma
    Lin, John K.
    Muffly, Lori S.
    Spinner, Michael A.
    Barnes, James, I
    Owens, Douglas K.
    Goldhaber-Fiebert, Jeremy D.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (24) : 2105 - +
  • [5] Economic Evaluation of Chimeric Antigen Receptor T-Cell Therapy by Site of Care Among Patients With Relapsed or Refractory Large B-Cell Lymphoma
    Lyman, Gary H.
    Nguyen, Andy
    Snyder, Sophie
    Gitlin, Matthew
    Chung, Karen C.
    [J]. JAMA NETWORK OPEN, 2020, 3 (04) : E202072
  • [6] Impact and Safety of Chimeric Antigen Receptor T Cell Therapy in Vulnerable Older Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma
    Lin, Richard J.
    Lobaugh, Stephanie M.
    Pennisi, Martina
    Chan, Jason T.
    Batlevi, Yakup
    Ruiz, Josel D.
    Elko, Theresa A.
    Maloy, Molly A.
    Batlevi, Connie Lee
    Dahi, Parastoo B.
    Giralt, Sergio A.
    Mead, Elena
    Noy, Ariela
    Palomba, Maria Lia
    Santomasso, Bianca
    Sauter, Craig S.
    Scordo, Michael
    Shah, Gunjan L.
    Korc-Grodzicki, Beatriz
    Kim, Soo Jung
    Silverberg, Mari Lynne
    Brooklyn, Chelsea A.
    Devlin, Sean M.
    Perales, Miguel-Angel
    [J]. BLOOD, 2019, 134
  • [7] Impact and safety of chimeric antigen receptor T-cell therapy in older, vulnerable patients with relapsed/refractory large B-cell lymphoma
    Lin, Richard J.
    Lobaugh, Stephanie M.
    Pennisi, Martina
    Chan, Hei Ton
    Batlevi, Yakup
    Ruiz, Josel D.
    Elko, Theresa A.
    Maloy, Molly A.
    Batlevi, Connie L.
    Dahi, Parastoo B.
    Hamlin, Paul A.
    Giralt, Sergio A.
    Hamlin, Paul A.
    Mead, Elena
    Noy, Ariela
    Palomba, M. Lia
    Santomasso, Bianca D.
    Sauter, Craig S.
    Scordo, Michael
    Shah, Gunjan L.
    Korc-Grodzicki, Beatriz
    Kim, Soo Jung
    Silverberg, Mari Lynne
    Brooklyn, Chelsea A.
    Devlin, Sean M.
    Perales, Miguel-Angel
    [J]. HAEMATOLOGICA, 2021, 106 (01) : 255 - 258
  • [8] Overcoming Barriers to Referral for Chimeric Antigen Receptor T Cell Therapy in Patients with Relapsed/Refractory Diffuse Large B Cell Lymphoma
    Hoffmann, Marc S.
    Hunter, Bradley D.
    Cobb, Patrick W.
    Varela, Juan C.
    Munoz, Javier
    [J]. TRANSPLANTATION AND CELLULAR THERAPY, 2023, 29 (07): : 440 - 448
  • [9] Cost-Effectiveness of Chimeric Antigen Receptor T-Cell Therapy in Pediatric Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia
    Sarkar, Reith R.
    Gloude, Nicholas J.
    Schiff, Deborah
    Murphy, James D.
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2019, 111 (07) : 719 - 726
  • [10] Cost-Effectiveness of Anti-BCMA Chimeric Antigen Receptor T Cell Therapy in Relapsed/Refractory Multiple Myeloma
    Yamamoto, Chihiro
    Minakata, Daisuke
    Yokoyama, Daizo
    Furuki, Shuka
    Noguchi, Atsuto
    Koyama, Shunsuke
    Oyama, Takashi
    Murahashi, Rui
    Nakashima, Hirotomo
    Ikeda, Takashi
    Kawaguchi, Shin-ichiro
    Hyodo, Kazuki
    Toda, Yumiko
    Ito, Shoko
    Nagayama, Takashi
    Umino, Kento
    Morita, Kaoru
    Ashizawa, Masahiro
    Ueda, Masuzu
    Hatano, Kaoru
    Sato, Kazuya
    Ohmine, Ken
    Fujiwara, Shin-ichiro
    Kanda, Yoshinobu
    [J]. TRANSPLANTATION AND CELLULAR THERAPY, 2024, 30 (01): : 118.e1 - 118.e15
12345